Trial NCT03418532

View at ClinicalTrials.gov 
Org. Study IDs: MP0250-CP202

Last trial update was posted on 2023-03-23

MeSH Interventions

Osimertinib

MeSH Conditions

Carcinoma, Non-Small-Cell Lung

Other Conditions

EGFR-mutated NSCLC (Disorder)

Stopping Reasons

Sponsor's decision

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID